Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma

Tumori

Volumn 95, Issue 6, 2009, Pages 828-831

  Gambini, Donatella ^a   Visintin, Roberto ^a   Locatelli, Elisa ^a   Galassi, Barbara ^a   Bareggi, Claudia ^a   Runza, Letterio ^a   Onida, Francesco ^b   Tomirotti, Maurizio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Antiangiogenic therapy; Metronomic therapy; Paclitaxel; Secondary breast angiosarcoma

Indexed keywords

PACLITAXEL;

AGED; ANGIOSARCOMA; ARTICLE; ASPIRATION BIOPSY; BREAST SARCOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; FEMALE; HUMAN; MASTECTOMY; THERAPY DELAY;

EID: 76349085187     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500631     Document Type: Article

References (23)

1. Cha C, Antonescu CR, Quan ML, Maru S, Brennan MF: Long-term results with resection of radiation-induced soft-tissue sarcomas. Ann Surg, 239: 903-909, 2004.
2. Penel N, Depadt G, Vilain MO, Vanseymortier L, Ceugnart L, Taieb S, Mirabel X, Deligny N, Chevalier A, Baranzelli MC, Pichon F, Hoguet D, Robin YM, Lartigau E: Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas. Bull Cancer, 90: 887-895, 2003.
3. Bousquet G, Confavreux C, Magné N, de Lara CT, Poortmans P, Senkus E, de Lafontan B, Bolla M, Largillier R, Lagneau E, Kadish S, Lemanski C, Ozsahin M, Belkacémi Y: Outcome and prognostic factors in breast sarcoma: a multicenter study from the Rare Cancer Network. Radiother Oncol, 85: 355-361, 2007.
4. Sleijfer S, Seynaeve C, Verweij J: Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care. Oncologist, 10: 833-841, 2005.
5. Von Mehren M: New therapeutic strategies for soft tissue sarcomas. Curr Treat Options Oncol, 4: 441-451, 2003.
6. Von Mehren M: New therapeutics for soft-tissue sarcomas in adults. Oncology (Williston Park), 21: 123-126, 2007.
7. Sher T, Hennessy BT, Valero V Broglio K, Woodward WA, Trent I, Hunt KK, Hortobagyi GN, Gonzalez-Angulo AM: Primary angiosarcoma of the breast. Cancer, 110: 173-178, 2007.
8. Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES: Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer, 86: 2034-2037, 1999.
9. Budd GT: Management of angiosarcoma. Curr Oncol Rep, 4: 515-519, 2002.
10. Pestoni C, Paredes-Suarez C, Peteiro C, Toribio J: Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel. J Eur Acad Dermatol Venereol, 19: 357-359, 2005.
11. Skubitz KM, Haddad PA: Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer, 104: 361-366, 2005.
12. Fury MG, Antonescu CR, Van Zee KJ, Brennan MF, Maki RG: A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J, 11: 241-247, 2005. Erratum in: Cancer J, 11: 354, 2005.
13. Mathew P, Vakar-Lopez F, Troncoso P: Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin. Lancet Oncol, 7: 92-93, 2006.
14. Mano MS, Fraser G, Kerr J, Gray M, Evans V, Kazmi A, Canney P: Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy. Breast, 15: 117-118, 2006.
15. Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo T, Nishigori C: Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer, 110: 648-651, 2007.
16. Ishibashi N, Mitachi Y, Sugawara S, Shinozaki S, Miura M, Fukuju T, Katahira Y, Koyama K, Fujikawa N, Kato T, Murakami K: A case of cardiac angiosarcoma successfully treated with docetaxel. Gan To Kagaku Ryoho, 34: 1849-1852, 2007.
17. Tada Y, Takiguchi Y, Terada I, Yoshida T, Shinozaki A, Sakao S, Kasahara Y, Kurosu K, Tanabe N, Tatsumi K, Hiroshima K, Kuriyama T: A case of angiosarcoma of pelvis with pulmonary metastases which responded to paclitaxel. Gan To Kagaku Ryoho, 34: 2275-2277, 2007.
18. Zelek L, Llombart-Cussac A, Terrier R Pivot X, Guinebretiere JM, Le Pechoux C, Tursz T, Rochard F, Spielmann M, Le Cesne A: Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol, 21: 2583-2588, 2003.
19. Abraham JA, Hornicek FJ, Kaufman AM, Harmon DC, Springfield DS, Raskin KA, Mankin HJ, Kirsch DG, Rosenberg AE, Nielsen GP, Desphpande V, Suit HD, DeLaney TF, Yoon SS: Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol, 14: 1953-1967, 2007.
20. Tomasello L, Gardin G, Boccardo F: Secondary breast angiosarcoma: lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report. Anticancer Res, 26: 4775-4777, 2006.
21. Pasquier E, Honoré S, Braguer D: Microtubule-targeting agents in angiogenesis: where do we stand? Drug Resist Updat, 9: 74-86, 2006.
22. Bocci G, Nicolau KC, Kerbel RS: Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res, 62: 6938-6943, 2002.
23. Kunstfeld R, Wickenhauser G, Michaelis U, Teifel M, Umek W, Naujoks K, Wolff K, Petzelbauer P: Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model. J Invest Dermatol, 120: 476-482, 2003.